Terms: = Prostate cancer AND SRSF2, Q01130, 6427, SFRS2
7 results:
1. Evaluating the activity of nonsense-mediated RNA decay via Nanopore direct RNA sequencing.
Li Y; Wan L; Zhang L; Zhuo Z; Luo X; Cui J; Liu Y; Su F; Tang M; Xiao F
Biochem Biophys Res Commun; 2022 Sep; 621():67-73. PubMed ID: 35810593
[TBL] [Abstract] [Full Text] [Related]
2. Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA.
Chen Z; Hu H
Curr Probl Cancer; 2019 Dec; 43(6):100503. PubMed ID: 31563279
[TBL] [Abstract] [Full Text] [Related]
3. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract] [Full Text] [Related]
5. Is There a Future for Chemoprevention of prostate cancer?
Bosland MC
Cancer Prev Res (Phila); 2016 Aug; 9(8):642-7. PubMed ID: 27099271
[TBL] [Abstract] [Full Text] [Related]
6. Mutational analysis of splicing machinery genes SF3B1, U2AF1 and srsf2 in myelodysplasia and other common tumors.
Je EM; Yoo NJ; Kim YJ; Kim MS; Lee SH
Int J Cancer; 2013 Jul; 133(1):260-5. PubMed ID: 23280334
[TBL] [Abstract] [Full Text] [Related]
7. Exon 11 skipping of E-cadherin RNA downregulates its expression in head and neck cancer cells.
Sharma S; Liao W; Zhou X; Wong DT; Lichtenstein A
Mol Cancer Ther; 2011 Sep; 10(9):1751-9. PubMed ID: 21764905
[TBL] [Abstract] [Full Text] [Related]
